EQS-News: Imcyse Announces Completion of Enrollment in Phase 2 IMPACT Trial of IMCY-0098 for Type 1 Diabetes
EQS-News: Imcyse SA / Key word(s): Study Imcyse Announces Completion of Enrollment in Phase 2 IMPACT Trial of IMCY-0098 for Type 1 Diabetes 01.03.2023 / 13:00 CET/CEST The issuer is solely responsible for the content of this announcement. Imcyse Announces Completion of Enrollment in Phase 2 IMPA...
Source: boersennews.de